Changeflow GovPing Pharma & Drug Safety Safety Alert: Maintenance of CO2 Laser and Vers...
Routine Notice Amended Final

Safety Alert: Maintenance of CO2 Laser and VersaPulse PowerSuite DW Systems by Boston Scientific

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Published
Detected
Email

Summary

ANSM registered safety action R2609352 regarding Boston Scientific's CO2 laser systems and dual-wavelength VersaPulse PowerSuite systems. Healthcare facilities using these laser devices have received a direct correspondence from Boston Scientific dated 16/04/2026 containing safety information. ANSM directs users with questions to contact Boston Scientific directly.

Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Boston Scientific has implemented a safety action concerning maintenance requirements for its CO2 laser systems and VersaPulse PowerSuite dual-wavelength laser systems. ANSM has registered this safety action under reference number R2609352 and notified pharmacy departments of health establishments and distributors of the manufacturer's communication.

Healthcare facilities using Boston Scientific CO2 laser or VersaPulse PowerSuite systems should review the manufacturer's correspondence received on 16/04/2026 and contact Boston Scientific directly for any questions regarding the safety information. Distributors and pharmacy departments should ensure relevant personnel are aware of this safety alert.

What to do next

  1. Contact Boston Scientific for information regarding this safety action

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

!share
Information n° R2609352 destinée aux pharmacies à usage intérieur des établissements de santé, distributeurs L'ANSM a été informée de la mise en œuvre d’une information de sécurité par la société Boston Scientific.
Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2609352.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité Consultez le courrier de la société Boston Scientific (16/04/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive
Document ID
R2609352

Who this affects

Applies to
Medical device makers Healthcare providers Distributors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device safety alert Device maintenance requirements
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Product Safety

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!